Clinical chemistry analyzers are automated devices utilized for the measurement and analysis of different levels of sugars, proteins, sugars and other products in the blood. Clinical chemistry testing is done to determine the clinical condition such as kidney function, liver function, nutritional state and others. Likewise, testing is widely adopted for the analysis of clinical conditions such as hyperlipidemia, diabetes, arteriosclerosis and as well for regular check up. The devices are highly technologically advanced and sophisticated and bring accurate results in the least time.
Download exclusive Sample of this report:
The market of clinical chemistry analyzers can be segmented on the basis of product, test, end users and geography. Based on types of test the report on clinical chemistry analyzers market can be segmented as liver panels, lipid profiles, electrolyte panels, thyroid function panels, renal profiles and basic metabolic panels. Furthermore, the market on clinical chemistry analyzers can be segmented into types of product which includes reagents, analyzers and other products. Likewise the market of clinical chemistry analyzers can be segmented into types of endusers namely hospitals, diagnostic laboratories, academic research institutes and others. In addition, the market can be segmented on the basis of sectors, such as, ultra-large, large, mid and small sector clinical chemistry analyzers. Further, the market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World.
The clinical chemistry market is driven by various factors, such as, technological advancements, increase in global number of in-vitro diagnostic tests and increased awareness about health and diagnostic tests amongst the population. Similarly, aging population and increasing prevalence of chronic diseases and criminal activities would increase the demand for diagnostic testing. Owing to technological advancement, large number of sophisticated and accurate chemistry analyzers are being introduced in the market, such as StaRRsedInversa Automated ESR analyzer and others. Increased focus on reduction of healthcare expenditure would also increase the demand for clinical chemistry analyzers as effective diagnosis would reduce the cost due to misdiagnosis. Similarly, rising number of point of care testing capabilities are also expected to boost the growth of this market. Likewise, increasing number of crime are also fuelling the demand of market, since the chemistry analyzers play a vital role in the investigations. According to FBI globally in 2012 more than 5 miilion crime realted cases were witnessed. However, high cost, need of highly qualified and trained personnel, and risk of result uncertainty are some of the market restraints.
View exclusive Global strategic Business report :
Geographically, the North American region is considered as the most dominating market. Currently, the U.S., Europe and Japan accounts for more than 60% share of the market. However, these regions are expected to witness decline in their market share due to market maturity and expansion of clinical diagnostics segment in the Asian region. Thus, Asia-Pacific region is anticipated to be the highest growing market for the forecast period.
This market is highly fragmented and many players are planning to launch new version of devices as to address the unmet needs. Beckman Coulter, Inc., Nova Biomedical Corporation, Abbott Diagnostics, Siemens AG, Thermo Fisher Scientific, Inc., Jhonson and Jhonson, Elitech Group, Mindray Medical International Limited, Horiba, Ltd., Ortho-Clinical Diagnostics, Inc., Sysmex Corporation are some of the major players operating in the global clinical chemistry analyzers market.